The last line from Diamond says it all...
" It is our goal to bring this medication to as many DMD patients worldwide as possible"
He wouldn't be stating this, if it wasn't the reality of the situation.
onwards and upwards.
Ann: US FDA Type C Meeting for ATL1102 in DMD, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.001(12.5%) |
Mkt cap ! $9.786M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 0.9¢ | 0.9¢ | $2.297K | 270.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 5578299 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 2117871 | 5 |
View Market Depth
| Last trade - 16.10pm 07/07/2025 (20 minute delay) ? |
| PER (ASX) Chart |